Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  12,212 results for ""VACCINES""

Your Filters

Publisher : bmj publishing group Filter by : Keyword
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.

  • Authors : Eyal N; Center for Population-Level Bioethics, Department of Philosophy (SAS) and Department of HBSP (SPH), Rutgers University, New Brunswick, New Jersey, USA .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans

  • Source: Journal of medical ethics [J Med Ethics] 2024 Mar 20; Vol. 50 (4), pp. 278-284. Date of Electronic Publication: 2024 Mar 20.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines.

  • Authors : Bai I; Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada .; Doshi P

Subjects: Biological Products*/Biological Products*/Biological Products*/therapeutic use ; Vaccines*; Canada

  • Source: BMJ evidence-based medicine [BMJ Evid Based Med] 2024 May 22; Vol. 29 (3), pp. 187-193. Date of Electronic Publication: 2024 May 22.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101719009 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

  • Authors : Ørbo HS; Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway .; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: RMD open [RMD Open] 2024 Apr 09; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 09.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?

  • Authors : Jeantin L; Department of Neurology, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France.; Abdi B

Subjects: Multiple Sclerosis*/Multiple Sclerosis*/Multiple Sclerosis*/drug therapy ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2023 Dec 14; Vol. 95 (1), pp. 19-28. Date of Electronic Publication: 2023 Dec 14.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 2985191R Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Vaccine mandates for prospective versus existing employees: reply to Smith.

  • Authors : Paetkau T; Philosophy, McGill University, Montreal, Québec, Canada .

Subjects: Mandatory Vaccination* ; Vaccines*; Humans

  • Source: Journal of medical ethics [J Med Ethics] 2024 Mar 20; Vol. 50 (4), pp. 285-286. Date of Electronic Publication: 2024 Mar 20.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2).

  • Authors : Tran AP; Department of Health and Medical Sciences, The University of Western Australia, Perth, Western Australia, Australia .; St John of God Private Hospital, Murdoch, Western Australia, Australia.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines* ; Antirheumatic Agents*

  • Source: RMD open [RMD Open] 2023 Mar; Vol. 9 (1).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

US adults' preferences for race-based and place-based prioritisation for COVID-19 vaccines.

  • Authors : Schmidt H; Department of Medical Ethics and Health Policy, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA .; Shaikh SJ

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: Journal of medical ethics [J Med Ethics] 2022 Jul; Vol. 48 (7), pp. 497-500. Date of Electronic Publication: 2021 Dec 31.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Analysis of the institutional landscape and proliferation of proposals for global vaccine equity for COVID-19: too many cooks or too many recipes?

Subjects: COVID-19* ; Vaccines*; Humans

  • Source: Journal of medical ethics [J Med Ethics] 2023 Aug; Vol. 49 (8), pp. 583-590. Date of Electronic Publication: 2021 Nov 30.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 7513619 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.

  • Authors : Frommert LM; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.; Arumahandi de Silva AN

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines* ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: RMD open [RMD Open] 2022 Dec; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination.

  • Authors : Habermann E; Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin Campus Charite Mitte, Berlin, Germany.; Gieselmann L

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*SARS-CoV-2 variants

  • Source: RMD open [RMD Open] 2022 Oct; Vol. 8 (2).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  12,212 results for ""VACCINES""